Fesoterodine
Fesoterodine fumarate extended-release tablets are indicated for the treatment of: Overactive bladder (OAB) in adults with symptoms of urge urinary incontinence, urgency, and frequency.
United States
$65
per month
India
$10
per month
You save
−85%save $55/mo · 85% cheaper
169.1K US scripts/yr$9.3M potential annual savings$11M US spend/yr
Drag to rotate · 3D structureC26H37NO3
SMILES: CC(C)C(=O)OC1=C(C=C(C=C1)CO)[C@H](CCN(C(C)C)C(C)C)C2=CC=CC=C2
Compare the price
US price$65per month
India price$10per month
You save$5585% less
Based on 30 units per month. US $2.16 vs India $0.32 per unit.
Total over 1 periodSave $55$65 → $10
The bigger picture
Fesoterodine is filled about 169.1K times a year under Medicare Part D. At the prices above, that works out to roughly:
Est. annual US spend
$11M
If sourced from India
$1.6M
Potential annual savings
$9.3M
−85%
Rough estimate. Based on Medicare Part D prescription volume (not the entire US market) scaled by the representative monthly price — actual totals depend on dose, duration and coverage.